Dataset Information

Inhibition of mTOR attenuates the initiation and progression of BRCA1-associated mammary tumors

ABSTRACT: We conducted global proteome and phosphoproteome profiling of vehicle- and everolimus-treated tumors from 17 mice that were allografted with spontaneously developed mammary tumors from Brca1co/coMMTV-Cre mice using LC-MS/MS. The Proteome Discoverer analysis identified 9,625 proteins having two unique sibling peptides and more and 35,142 phosphopeptides with a peptide- and protein-level FDR of 1% using SEQUEST-HT algorithm. We defined everolimus-sensitive and resistant tumors based on proteome and phosphoproteome data, and identified protein and phosphopeptide signatures defining each cluster. Pathway enrichment analysis of these signatures further revealed that leukotriene-neutrophil activation pathways were upregulated in everolimus-resistant tumors.

INSTRUMENT(S):

ORGANISM(S): Mus Musculus (mouse)

TISSUE(S): Mammary Gland

SUBMITTER: Geun Hee Han

LAB HEAD: Daehee Hwang

PROVIDER: PXD054301 | Pride | 2025-01-24

REPOSITORIES: Pride

ACCESS DATA

Dataset's files

Source:

			Action	DRS
	KSS_TMTpro_MS2_Global.mgf	Mgf
	KSS_TMTpro_MS2_Global.mzid.gz	Mzid
	KSS_TMTpro_MS2_Global_S01_F01.raw	Raw
	KSS_TMTpro_MS2_Global_S01_F02.raw	Raw
	KSS_TMTpro_MS2_Global_S01_F03.raw	Raw

Items per page:

1 - 5 of 81

Publications

Inhibition of mTOR attenuates the initiation and progression of BRCA1-associated mammary tumors.

Baek Hye Jung HJ Han Geun Hee GH Cho Eun Joo EJ Xu Jihao J Ki Min Kyung MK Park Eun Jung EJ Kim Tae Hyun TH Shin Dong Hoon DH Cheong Heesun H Deng Chu-Xia CX Lim Sung Chul SC Hwang Chang-Il CI Hwang Daehee D Kim Sang Soo SS

Cancer communications (London, England) 20250118 4

PMID: 39826130

Similar Datasets

Project description:Purpose: To define copy number alterations and gene expression signatures underlying pediatric high-grade glioma (HGG). Patients and Methods: We conducted a high-resolution analysis of genomic imbalances in 78 de novo pediatric HGG, including 7 diffuse intrinsic pontine gliomas, and 10 HGG cases arising in children who received cranial irradiation for a previous cancer, using Affymetrix 500K GeneChips. Gene expression signatures for 53 tumors were analyzed with Affymetrix U133v2 arrays. Results were compared with publicly available data from adult tumors. Results: Pediatric and adult glioblastoma were clearly distinguished by frequent gain of chromosome 1q (30% vs 9%) and lower frequency of chromosome 7 gain (13% vs 74%), respectively. The most common focal amplifications also differed, with PDGFRA and EGFR predominant in childhood and adult populations respectively. These common alterations in pediatric HGG were detected at higher frequency in irradiation-induced tumors, suggesting that these are initiating events in childhood gliomagenesis. CDKN2A was the most common tumor suppressor gene targeted by homozygous deletion in pediatric HGG. No IDH1 hotspot mutations were found in pediatric tumors, highlighting molecular differences in pathogenesis between childhood HGG and adult secondary glioblastoma. Integrated copy number and gene expression data indicated that deregulated PDGFRA signaling plays a major role in pediatric HGG. Conclusions: Integrated molecular profiling showed substantial differences in the molecular features underlying pediatric and adult HGG, indicating that findings in adult tumors cannot be simply extrapolated to younger patients. PDGFRA may be a useful target for pediatric HGG including diffuse pontine gliomas. Keywords: disease state analysis 78 samples for SNP analysis, including 10 samples arising in children who received cranial irradiation for a previous cancer and 7 diffuse pontine gliomas; 53 of them with gene expression analysis; 2 tumor grades To have access to SNP CEL files, please contact Dr. Suzanne Baker (suzzane.baker@stjude.org).